Inhibition of NF-κB Activity Enhances Sensitivity to Anticancer Drugs in Cholangiocarcinoma Cells

Cholangiocarcinoma (CCA) is a dismal cancer. At present, there is no effective chemotherapeutic regimen for CCA. This may be due to the marked resistance of CCA to chemotherapy drugs, for which a mechanism remains unknown. Nuclear factor-κB (NF-κB) is constitutively activated in a variety of cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Seubwai, Wunchana, Vaeteewoottacharn, Kulthida, Kraiklang, Ratthaphol, Umezawa, Kazuo, Okada, Seiji, Wongkham, Sopit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cognizant Communication Corporation 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7842550/
https://www.ncbi.nlm.nih.gov/pubmed/26802647
http://dx.doi.org/10.3727/096504015X14424348426071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7842550/
https://www.ncbi.nlm.nih.gov/pubmed/26802647
http://dx.doi.org/10.3727/096504015X14424348426071

Ejemplares similares